Using Flavonoid Substitution Status to Predict Anticancer Effects in Human Melanoma Cancers: An In Vitro Study

Skin cancers are a dominant type of cancer that impacts millions per year. Cancer is a heterogeneous disease triggered by the irreversible impairment of cellular homeostasis and function. In this study, we investigated the activity of 37 structurally diverse flavonoids to find potentially active sub...

Full description

Bibliographic Details
Main Authors: Katarzyna Jakimiuk, Łukasz Szoka, Arkadiusz Surażyński, Michał Tomczyk
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/16/3/487
_version_ 1797319044176543744
author Katarzyna Jakimiuk
Łukasz Szoka
Arkadiusz Surażyński
Michał Tomczyk
author_facet Katarzyna Jakimiuk
Łukasz Szoka
Arkadiusz Surażyński
Michał Tomczyk
author_sort Katarzyna Jakimiuk
collection DOAJ
description Skin cancers are a dominant type of cancer that impacts millions per year. Cancer is a heterogeneous disease triggered by the irreversible impairment of cellular homeostasis and function. In this study, we investigated the activity of 37 structurally diverse flavonoids to find potentially active substances using two melanoma cell lines: C32 and A375. First, the cytotoxic potential and DNA biosynthesis inhibition of flavonoids were tested to determine the most active compounds in cancer and normal cells. Second, the molecular mechanism of the anticancer activity of flavonoids was elucidated using Western blot and immunofluorescence analyses. Compounds <b>1</b>, <b>6</b>, <b>15</b>, and <b>37</b> reduced the viability of A375 and C32 cell lines via the intrinsic and extrinsic pathways of apoptosis, whereas <b>16</b> and <b>17</b> acted in a higher degree via the inhibition of DNA biosynthesis. In our experiment, we demonstrated the anticancer activity of compound <b>15</b> (5,6-dihydroxyflavone) for the first time. The in vitro studies pointed out the importance of the flavonoid core in hydroxyl groups in the search for potential drugs for amelanotic melanoma.
first_indexed 2024-03-08T04:01:05Z
format Article
id doaj.art-e96f66e831f24fda835d4c46776bb60a
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-08T04:01:05Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-e96f66e831f24fda835d4c46776bb60a2024-02-09T15:08:41ZengMDPI AGCancers2072-66942024-01-0116348710.3390/cancers16030487Using Flavonoid Substitution Status to Predict Anticancer Effects in Human Melanoma Cancers: An In Vitro StudyKatarzyna Jakimiuk0Łukasz Szoka1Arkadiusz Surażyński2Michał Tomczyk3Department of Pharmacognosy, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Białystok, ul. Mickiewicza 2a, 15-230 Białystok, PolandDepartment of Medicinal Chemistry, Euroregional Center of Pharmacy, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Białystok, ul. Mickiewicza 2d, 15-222 Białystok, PolandDepartment of Medicinal Chemistry, Euroregional Center of Pharmacy, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Białystok, ul. Mickiewicza 2d, 15-222 Białystok, PolandDepartment of Pharmacognosy, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Białystok, ul. Mickiewicza 2a, 15-230 Białystok, PolandSkin cancers are a dominant type of cancer that impacts millions per year. Cancer is a heterogeneous disease triggered by the irreversible impairment of cellular homeostasis and function. In this study, we investigated the activity of 37 structurally diverse flavonoids to find potentially active substances using two melanoma cell lines: C32 and A375. First, the cytotoxic potential and DNA biosynthesis inhibition of flavonoids were tested to determine the most active compounds in cancer and normal cells. Second, the molecular mechanism of the anticancer activity of flavonoids was elucidated using Western blot and immunofluorescence analyses. Compounds <b>1</b>, <b>6</b>, <b>15</b>, and <b>37</b> reduced the viability of A375 and C32 cell lines via the intrinsic and extrinsic pathways of apoptosis, whereas <b>16</b> and <b>17</b> acted in a higher degree via the inhibition of DNA biosynthesis. In our experiment, we demonstrated the anticancer activity of compound <b>15</b> (5,6-dihydroxyflavone) for the first time. The in vitro studies pointed out the importance of the flavonoid core in hydroxyl groups in the search for potential drugs for amelanotic melanoma.https://www.mdpi.com/2072-6694/16/3/487flavonoidsmelanomastructure–activity relationship
spellingShingle Katarzyna Jakimiuk
Łukasz Szoka
Arkadiusz Surażyński
Michał Tomczyk
Using Flavonoid Substitution Status to Predict Anticancer Effects in Human Melanoma Cancers: An In Vitro Study
Cancers
flavonoids
melanoma
structure–activity relationship
title Using Flavonoid Substitution Status to Predict Anticancer Effects in Human Melanoma Cancers: An In Vitro Study
title_full Using Flavonoid Substitution Status to Predict Anticancer Effects in Human Melanoma Cancers: An In Vitro Study
title_fullStr Using Flavonoid Substitution Status to Predict Anticancer Effects in Human Melanoma Cancers: An In Vitro Study
title_full_unstemmed Using Flavonoid Substitution Status to Predict Anticancer Effects in Human Melanoma Cancers: An In Vitro Study
title_short Using Flavonoid Substitution Status to Predict Anticancer Effects in Human Melanoma Cancers: An In Vitro Study
title_sort using flavonoid substitution status to predict anticancer effects in human melanoma cancers an in vitro study
topic flavonoids
melanoma
structure–activity relationship
url https://www.mdpi.com/2072-6694/16/3/487
work_keys_str_mv AT katarzynajakimiuk usingflavonoidsubstitutionstatustopredictanticancereffectsinhumanmelanomacancersaninvitrostudy
AT łukaszszoka usingflavonoidsubstitutionstatustopredictanticancereffectsinhumanmelanomacancersaninvitrostudy
AT arkadiuszsurazynski usingflavonoidsubstitutionstatustopredictanticancereffectsinhumanmelanomacancersaninvitrostudy
AT michałtomczyk usingflavonoidsubstitutionstatustopredictanticancereffectsinhumanmelanomacancersaninvitrostudy